Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.38M | -3.26M | -3.37M | -3.04M | -2.28M |
| Total Depreciation and Amortization | 289.60K | 343.80K | 433.30K | 438.20K | 412.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Net Operating Assets | -3.32M | -2.91M | -1.82M | 187.90K | 327.20K |
| Cash from Operations | -6.41M | -5.83M | -4.76M | -2.41M | -1.54M |
| Capital Expenditure | -13.40K | -31.60K | -64.80K | -35.90K | -94.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -13.40K | -31.60K | -64.80K | -35.90K | -94.20K |
| Total Debt Issued | 1.33M | 1.28M | 1.51M | 1.77M | 2.05M |
| Total Debt Repaid | -848.80K | -837.60K | -- | -- | -- |
| Issuance of Common Stock | 5.49M | 5.49M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 16.80K | 0.00 | 5.52M | -85.40K | -102.20K |
| Cash from Financing | 5.99M | 5.93M | 7.02M | 1.69M | 1.95M |
| Foreign Exchange rate Adjustments | 439.50K | 218.40K | 318.80K | 642.90K | -255.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.50K | 295.90K | 2.52M | -119.40K | 59.80K |